Compare Bioavailability of RO7239361 After Subcutaneous Injection

An Open-label, Randomized, Parallel-group, Single Dose Study to Compare the Bioavailability of Subcutaneous Injections in the Arm, Thigh, and Abdomen and to Evaluate the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of RO7239361 in Healthy Participants

Randomized study in healthy men and women. Assess the similarity of RO7239361 when injected into the arm, thigh, or the stomach. Collect data on safety of RO7239361.

Inclusion Criteria:

• Healthy participant as determined by no significant deviations in normal medical and surgical history and assessments
• Body Mass Index 18 kg/m2 to 32 kg/m2
• females must be of non-childbearing potential

Exclusion Criteria:

• tattoos or other skin findings on any of the potential injection sites
• history of chronic muscle pain within 30 days prior to study treatment
• prior history of IgG1 therapy

Other protocol defined inclusion and exclusion criteria apply